Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Silver Bullet Creates Credibility

Finding credibility It is very difficult for a new issuer to find goodwill in the capital markets. Historically, and we all have a story to add to this, not every company has told the truth or, in some cases, even known what the truth was, leading to jaded hearts, apathet...

Gold Company's 'Ramp-up to Commercial Production on Track for Q2/20'

An update on the project and its production is provided in a Haywood report. In a Jan. 10 research note, Haywood analyst Kerry Smith reported that Lundin Gold Inc. (LUG:TSX) remains on track and on budget to achieve commercial production at its Fruta del Norte proje...

A “Golden” Opportunity Across Two Continents

When we last net up with Canada-based gold producer and explorer Galane Gold Ltd. (GG) ( TSX-V.GG , OTCQB: GGGOF , Forum ) in January, company CEO Nick Brodie introduced our Stockhouse investor audience to its advanced operation of gold mining properties in the Botswana...

Kiniksa Shares Trade Up 30% on COVID-19 Pneumonia and Hyperinflammation Treatment

Shares of Kiniksa Pharmaceuticals traded higher after the company reported early success in treatment response for mavrilimumab in six patients with severe COVID-19 pneumonia and hyperinflammation. This morning, Hamilton, Bermuda based biopharmaceutical comp...

Chimerix Shares Rise 50% as FDA Gives 'Go Ahead' for Phase 2/3 ALI Study in COVID-19 Patients

Shares of Chimerix Inc. traded higher after the company reported it has received U.S. FDA clearance to initiate a Phase 2/3 Study of dociparstat sodium in acute lung injury for patients afflicted with severe COVID-19. Biopharmaceutical company Chimerix Inc....

Regenerative Medicine Firm Reports Early Results from COVID-19 Trials

Pluristem Therapeutics' coronavirus clinical studies and financing are discussed in a Dawson James report. In a June 11 research note, Dawson James analyst Jason Kolbert reported that Pluristem Therapeutics Inc. (PSTI:NASDAQ) announced the status of COVID-19-infe...

Buzz on the Bullboards: 2021’s Highlights

2021 was another year of ups, downs, and everything in between, but it was also a year marked by continued global economic uncertainty and a shakeup of some of the hottest investment sectors. I took notice when I realized how often I had been updating my template...

Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19

Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil. Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW:FSE) , a Canada-based clinical stage drug development company that focuses on drug repurposing, believes ...

May 25th 2020, Crypto Chartbook: Built not bought

Built not bought This isn’t just a catchy phrase. It is the only way to riches. It is statistically proven that most market speculators, that try to blindly follow a trading recommendation fail to produce consistent results. Why? The most difficult part in ...

It Can Take a Lifetime to Build a Good Company, But Only a Minute to Ruin

(Challenger 350 interior image via Bombardier Inc.) Much like that Will Rogers quote that is all too real, even these days … The world is trying to get as close to a “pre-pandemic” norm as it can and nowhere is this movement more evident than i...
1 2 3 4 5 6 7 8 9 10 ...